Turkish researchers have produced an anti-serum against Crimean-Congo Hemorrhagic Fever (CCHF) by using blood samples from patients who developed immunity after recovering from the disease.
Turski istraživači proizveli su serum protiv Krimen-Kongo hemoralgične groznice (CCHF), koristeći uzorke krvi pacijenata koji su razvili imunitet posle oporavka od te bolesti.